Lysosomal storage
We provide diagnosis, treatment and long-term management for people affected by lysosomal storage diseases. Care is delivered through a personalized, multi-disciplinary approach focused on complex, multi-system conditions.
Lysosomal Storage Disease Program
Our program provides comprehensive and personalized clinical care for patients affected by lysosomal storage diseases (LSDs). These are genetic disorders caused by defects within cells. For patients affected by LSDs, our program offers diagnosis, management and treatment. We also provide monitoring of several treatments including enzyme replacement therapy, substrate reduction therapy and oral therapy.
Our team has the experience and resources to treat a wide range of complications commonly seen in these inherited metabolic diseases. We are committed to integrating clinical research, teaching and patient care, and our program is often involved in clinical studies, including clinical trials with the most advanced therapeutic agents.
The program is unique for its integrated approach to patients affected by multi-systemic lysosomal diseases, while following Atlantic Health’s principles of the pursuit of excellence and innovation in patient care.